Detection of Factor VIII Inhibitors in Hemophilia A Patients
Journal Title: Iranian Journal of Blood and Cancer - Year 2012, Vol 4, Issue 4
Abstract
Background: Factor VIII administration to hemophilia A patients results in an immune response (inhibitor formation) which significantly complicates the therapy. The present study was performed to determine the prevalence of inhibitor development in hemophilia A patients receiving recombinant factor VIII therapy. Materials and Methods: This was an observational descriptive study. Clotting factor inhibitor screening was performed by activated partial thromboplastin time mixing studies using normal pool plasma collected from twenty healthy donors. Bethesda assay for quantitation of factor VIII inhibitors was performed on samples which were positive with screening tests. Results: Out of 229 patients with hemophilia A enrolled in the hemophilia society of Pakistan, Lahore center, 50 patients were selected. The mean factor VIII level in these patients was 2.46 +3.14. Out of 50 patients, 29 (58%) had severe hemophilia A (factor VIII level <1%), 17 (34%) had moderate hemophilia A (factor VIII level 1-5%) and 4 (12%) had mild hemophilia A (factor VIII level >5-30%). In this study, 12 patients (24%) were positive for inhibitors. Most of them 9 (75%) were low responders (<5 Bethesda units) with a mean Bethesda units of 1.82+0.473, while 3 (25%) patients were high responders (>5 Bethesda units) with a mean BU of 11.33+5.85. Patients were divided into two groups on the basis of the number of factor VIII concentrate therapies of <50 (group 1) times and >50 times (group 2). Inhibitor positivity was high (34.5%) in group I, as compared to group II (9.5%). Bleeding episodes were also more common in inhibitors positive patients. Conclusion: In this study, the inhibitor development in patients with hemophilia A receiving recombinant factor VIII concentrates therapy was 24% and the first fifty therapies were crucial for inhibitor development.
Authors and Affiliations
Sh. Mohsin, J. Jaffar, M. Ikram Ullah, S. Amjad
Keywords
Related Articles
- EP ID EP368569
- DOI -
- Views 59
- Downloads 0
Hemophilia
This article has no abstract.
Range Determination of Antigen Expression in Myeloid, Erythroid and Lymphoid Cell Lineages among Patients with Myelodysplastic Syndrome
Background: Myelodysplastic syndrome is a mixed clonal disorder of bone marrow progenitor cells. Understanding the pattern of the different lineage-specific, immature, and mature markers in myelodysplastic syndrome will...
Myelofibrosis due to Secondary Hyperparathyroidism in a Case of Celiac Disease
Myelofibrosis is reported in patents with primary hyperparathyroidism. It is also was reported in patents with sec- ondary hyperparathyroidism due to end-stage renal disease or Vitamin D dependent rickets .We present a c...
Results of Transcranial Doppler in Children with Sickle Cell Disease: Correlation between the Time-Averaged Mean of Maximum Velocity and Some Hematological Characteristics
Abstract Background: Transcranial Doppler ultrasonography results have not been previously studied in among Iranian sickle cell anemia patients. The present study was performed to evaluate the pattern of intracranial flo...
Quality Assurance and Good Manufacturing Practice in Respect of Plasma Fractionation
The Quality centers shall build up a quality system. This comprises all activi-ties in the blood center intended to ensure that all blood and all components have a quality corresponding to the intended use. Quality Assu...